NCT00419341 - Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Primary Immune Deficiency

Interventions

BIOLOGICAL

Human Normal Immunoglobulin for Subcutaneous Administration

Trial Locations (13)

Study Site, New York

Study Site, Philadelphia

Study Site, Atlanta

Study Site, North Palm Beach

Study Site, Indianapolis

Study Site, Fort Wayne

Study Site, Iowa City

Study Site, Dallas

Study Site, Centennial

Study Site, Los Angeles

Study Site, Los Angeles

Study Site, St Louis

Study Site, Newark